Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells. | Cancers (Basel) | 2022 | 36230871 | PubTator, text mining | PubMed |
| Tumor-Associated Neutrophils in Colorectal Cancer Development, Progression and Immunotherapy. | Cancers (Basel) | 2022 | 36230676 | PubTator, text mining | PubMed |
| Oncolytic Adenoviruses: The Cold War against Cancer Finally Turns Hot. | Cancers (Basel) | 2022 | 36230621 | PubTator, text mining | PubMed |
| CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy. | Hum Vaccin Immunother | 2022 | 36222759 | PubTator, text mining | PubMed |
| Selective autophagy of RIPosomes maintains innate immune homeostasis during bacterial infection. | EMBO J | 2022 | 36221902 | PubTator, text mining | PubMed |
| Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes. | Cancer Cell Int | 2022 | 36217206 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma. | Front Genet | 2022 | 36212138 | PubTator, text mining | PubMed |
| Efficacy of bivalent CEACAM6/4-1BBL genetic vaccine combined with anti-PD1 antibody in MC38 tumor model of mice. | Heliyon | 2022 | 36212004 | PubTator, text mining | PubMed |
| Membrane attack complexes, endothelial cell activation, and direct allorecognition. | Front Immunol | 2022 | 36211400 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA. | Front Immunol | 2022 | 36211333 | PubTator, text mining | PubMed |
| Decoding the colorectal cancer ecosystem emphasizes the cooperative role of cancer cells, TAMs and CAFsin tumor progression. | J Transl Med | 2022 | 36209225 | PubTator, text mining | PubMed |
| LFA-1/ ICAM-1 promotes NK cell cytotoxicity associated with the pathogenesis of ocular toxoplasmosis in murine model. | PLoS Negl Trop Dis | 2022 | 36206304 | PubTator, text mining | PubMed |
| Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia. | Signal Transduct Target Ther | 2022 | 36202780 | PubTator, text mining | PubMed |
| Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification. | Environ Health Perspect | 2022 | 36201310 | PubTator, text mining | PubMed |
| Targeting 4-1BB for tumor immunotherapy from bench to bedside. | Front Immunol | 2022 | 36189243 | PubTator, text mining | PubMed |
| Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma. | Front Oncol | 2022 | 36185274 | PubTator, text mining | PubMed |
| The role and application of small extracellular vesicles in breast cancer. | Front Oncol | 2022 | 36185265 | PubTator, text mining | PubMed |
| 4-1BB: A promising target for cancer immunotherapy. | Front Oncol | 2022 | 36185242 | PubTator, text mining | PubMed |
| Single cell sequencing analysis and transcriptome analysis constructed the liquid-liquid phase separation(LLPS)-related prognostic model for endometrial cancer. | Front Oncol | 2022 | 36185238 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=38